Trial intelligence / Profile preview

Huoluotongnao Tablet in Post-stroke Cerebral Infarction (Blood Stasis Obstructing Collaterals)

CTR20160985Phase 2Active

Sponsor
Boji Medical Technology Co.,Ltd.
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Huoluotongnao in brain infarction, ischemic stroke, sponsored by Boji Medical Technology Co.,Ltd.. Started Dec 2016; status: active.

02

Drugs

Huoluotongnao
03

Conditions

brain infarctionischemic stroke

Beyond the preview

Go deeper on CTR20160985.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160985.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call